2370 On Other Exchanges
Symbol
Exchange
2370 is not on other exchanges.

medinet co ltd (2370) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDINET CO LTD (2370)

Related News

No related news articles were found.

medinet co ltd (2370) Related Businessweek News

No Related Businessweek News Found

medinet co ltd (2370) Details

MEDINET Co., Ltd. provides immuno-cell therapy total support services to medical institutions in Japan. Its immuno-cell therapy total support services include the provision of design, layout, installation, and operation management of cell processing facilities; biotechnology for cell culture and processing, and know-how for quality control; cell engineers for cell processing and quality check; materials, reagents, and consumables supply services; and custom-made medical practice management system. The company offers various types of immuno-cell therapy, such as dendritic cell vaccine therapy, natural killer-cell therapy, gamma-delta T-cell therapy, alpha-beta T-cell therapy, and cytotoxic T-lymphocyte therapy. MEDINET Co., Ltd. was founded in 1995 and is headquartered in Yokohama, Japan.

180 Employees
Last Reported Date: 12/17/15
Founded in 1995

medinet co ltd (2370) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medinet co ltd (2370) Key Developments

MEDINET Co., Ltd. Announces Consolidated Financial Results for the Six Months Ended March 2016; Provides Guidance for the Year Ending September 2015

MEDINET Co., Ltd. announced consolidated financial results for the six months ended March 2016. For the period, the company reported net sales of ¥926 million against ¥863 million a year ago. Operating loss was ¥739 million against ¥739 million a year ago. Net loss was ¥791 million against ¥638 million a year ago. Net loss per share was ¥8.78 against ¥7.23 a year ago. Loss before income taxes was ¥787.745 million against ¥600.247 million a year ago. Net cash flows used in operating activities was ¥410.973 million against ¥757.161 million a year ago. Cash outflow from purchase of property, plant and equipment was ¥9.237 million against ¥411.007 million a year ago. Cash outflow from purchase of intangible assets was ¥28.943 million against ¥56.732 million a year ago. The company expects net sales of ¥2,184 million, operating loss of ¥2,355 million, and net loss of ¥2,345 million or ¥25.76 per share for the year ending September 2016.

MEDINET Co., Ltd., Q2 2016 Earnings Call, May 24, 2016

MEDINET Co., Ltd., Q2 2016 Earnings Call, May 24, 2016

MEDINET Co., Ltd. to Report Q2, 2016 Results on May 10, 2016

MEDINET Co., Ltd. announced that they will report Q2, 2016 results at 3:00 PM, Tokyo Standard Time on May 10, 2016

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2370 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2370.
View Industry Companies
 

Industry Analysis

2370

Industry Average

Valuation 2370 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.4x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDINET CO LTD, please visit www.medinet-inc.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.